Pharmaceuticals

Prevention, Diagnosis & Treatment

Prevention, Diagnosis & Treatment

Bayer’s brands treat and prevent conditions to improve quality of life.

Pharma News

September 20, 2019

Bayer data at ESMO 2019 highlights innovation in cancer research

Bayer will present new data from the company's expanding oncology business at the European Society for Medical Oncology (ESMO) Congress 2019, taking place September 27 to October 1 in Barcelona,...

Learn more
August 08, 2019

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...

Learn more
July 30, 2019

FDA approves Bayer's Nubeqa® (darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer

The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant...

Learn more
Newsroom